Dimitri Bragilovski
Petah Tiqwa, M, Israel
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Two-year toxicity and PSA dynamics in the initial cohort of the SABR-Dual trial - two-fraction stereotactic radiotherapy for localized prostate cancer using rectal spacing.
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: February 04, 2026
Acute Toxicity and Early Prostate Specific Antigen Response After Two-Fraction Stereotactic Radiation Therapy for Localized Prostate Cancer Using Peri-Rectal Spacing-Initial Report of the SABR-Dual Trial.
Journal: International journal of radiation oncology, biology, physics
Published: April 18, 2024
The role of a radiopaque peri-rectal hydrogel spacer in aiding accurate daily image-guidance for prostate stereotactic radiotherapy.
Journal: Frontiers in oncology
Published: February 14, 2024
SABR-Dual: a phase II/III trial of two-fraction versus five-fraction stereotactic radiotherapy for localized low- and favorable intermediate-risk prostate cancer.
Journal: BMC cancer
Published: July 06, 2023
The Theoretical Value of Whole-Lung Irradiation for COVID-19 Pneumonia: A Reasonable and Safe Solution until Targeted Treatments are Developed.
Journal: Radiation research
Published: November 24, 2020
Stereotactic body radiation therapy (SBRT) for definitive treatment and as a bridge to liver transplantation in early stage inoperable Hepatocellular carcinoma.
Journal: Radiation oncology (London, England)
Published: June 21, 2017
Cisplatin-conjugated gold nanoparticles as a theranostic agent for head and neck cancer.
Journal: Head & neck
Published: March 09, 2017
Can molecular profiling enhance radiotherapy? Impact of personalized targeted gold nanoparticles on radiosensitivity and imaging of adenoid cystic carcinoma.
Journal: Theranostics
Published: February 12, 2017
Showing 1-10 of 10
Last Updated: 09/26/2026